Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Tesofensine effects on weight lead to phase III investigation

Nov. 10, 2009

Interim results of phase III study with CIMAvax EGF vaccine in NSCLC reported

Nov. 10, 2009

Bupropion improves hypoactive sexual desire disorder in women

Nov. 10, 2009

Phase III results show activity of omiganan 1% gel against catheter-related infections

Nov. 10, 2009

AIDS Vaccine meeting snapshots: Phase I and II trials of candidate vaccines

Nov. 9, 2009

Phase I study finds potential for rontalizumab in systemic lupus erythematosus

Nov. 9, 2009

Nicotinic alpha4beta2 receptor modulator A-969933 alters the stimulant effects of nicotine

Nov. 9, 2009

NOP receptor agonist SCH-655842 exhibits anxiolytic activity in preclinical models

Nov. 9, 2009

SUVN-623 shows promising activity in animal models of cognition

Nov. 9, 2009

AMPA receptor potentiator PF-4778574 safe and active in preclinical models of cognition

Nov. 9, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...